Effects of Different Doses of Virtual Reality Therapy in Chronic Stroke Patients (NCT07656987) | Clinical Trial Compass
CompletedNot Applicable
Effects of Different Doses of Virtual Reality Therapy in Chronic Stroke Patients
Turkey (Türkiye)43 participantsStarted 2025-08-15
Plain-language summary
This study aimed to compare the effects of different doses of Wii Fit-based virtual reality (VR) therapy added to conventional rehabilitation in patients with chronic stroke. Forty-three patients were randomly assigned to three groups: a control group receiving conventional rehabilitation only (5 days/week, 45 min/session for 4 weeks), a VR3 group receiving conventional rehabilitation plus VR training three days per week (20 min/session, 12 sessions total), and a VR5 group receiving conventional rehabilitation plus VR training five days per week (20 min/session, 20 sessions total). Balance (Berg Balance Scale), functional independence (Functional Independence Measure), stroke-specific quality of life (SS-QOL), static postural alignment (Becure Posture Mobile), and center of pressure measurements (Becure Balance System) were assessed before treatment (T0), after treatment (T1), and at one-month follow-up (T2). This prospective, single-blind, randomized controlled trial was conducted at Istanbul Physical Medicine Rehabilitation Training and Research Hospital.
Who can participate
Age range
20 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of ischemic or hemorrhagic stroke confirmed by CT or MRI
* Chronic stroke (onset ≥ 6 months prior to enrollment)
* Age between 20 and 75 years
* Mini-Mental State Examination (MMSE) score ≥ 18 (or MMSE-E for illiterate patients)
* Willingness to participate and provide written informed consent
Exclusion Criteria:
* Mini-Mental State Examination (MMSE) score \< 18
* Diagnosis of epilepsy
* Diagnosis of intellectual disability
* Visual and/or hearing impairment at a level that would affect participation in treatment methods
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested virtual reality therapy at different doses for chronic stroke — can you tell me what the results showed about which dose had the most effect on balance, and whether those findings might apply to my situation?
2Since this study used the Berg Balance Scale as its main measure, how does my current balance score on that scale compare to the kinds of patients who likely participated, and does that affect whether this approach could be right for me?
3The trial is already completed — does that mean the results have been published somewhere, and can we look at them together to understand whether virtual reality therapy is something worth pursuing as part of my recovery plan?
4How does virtual reality therapy compare to the balance and rehabilitation treatments I'm already doing or could do through standard care, and would adding it on top of those make sense for where I am in my stroke recovery?
5Since this was listed as 'Phase NA,' meaning it wasn't a traditional drug trial, what does that tell us about how confident doctors can be in the safety and effectiveness of virtual reality therapy for chronic stroke patients like me?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Berg Balance Scale (BBS)
Timeframe: Baseline (T0), post-treatment at 4 weeks (T1), and one-month follow-up (T2)
Trial details
NCT IDNCT07656987
SponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital